Roger Adsett - 07 Jan 2025 Form 4 Insider Report for INSMED Inc (INSM)

Reporting relationship: Chief Operating Officer
Issuer ticker: INSM
Reported as of: 07 Jan 2025
Net transaction value: -$597,759
SEC form: 4
Accepted by SEC: 10 Jan 2025, 18:44:35 UTC
Prior SEC filing: 23 May 2024
Next SEC filing: 16 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Roger Adsett, by Michael A. Smith as Attorney-in-fact

Key filing fact

Roger Adsett filed Form 4 for INSMED Inc (INSM) on 10 Jan 2025.

Key facts

This page summarizes Roger Adsett's Form 4 filing for INSMED Inc (INSM).
6 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 Jan 2025, 18:44.

Change

Previous filing in this sequence was filed on 23 May 2024.
Current net transaction value: -$597,759.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INSM transaction

Common Stock

Sale

Transaction value: $161,182
Shares: -2,444
Change %: -1.6%
Price: $65.95
Shares after: 147,666
Date: 07 Jan 2025
Ownership: Direct
Footnotes: F1, F2, F3

INSM transaction

Common Stock

Sale

Transaction value: $124,400
Shares: -1,882
Change %: -1.3%
Price: $66.10
Shares after: 145,784
Date: 08 Jan 2025
Ownership: Direct
Footnotes: F1

INSM transaction

Common Stock

Award

Transaction value
Shares: +6,657
Change %: +4.6%
Price
Shares after: 152,441
Date: 08 Jan 2025
Ownership: Direct
Footnotes: F4, F5

INSM transaction

Common Stock

Sale

Transaction value: $82,890
Shares: -1,298
Change %: -0.85%
Price: $63.86
Shares after: 151,143
Date: 10 Jan 2025
Ownership: Direct
Footnotes: F1

INSM transaction

Common Stock

Sale

Transaction value: $229,286
Shares: -3,604
Change %: -2.4%
Price: $63.62
Shares after: 147,539
Date: 10 Jan 2025
Ownership: Direct
Footnotes: F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INSM transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +31,930
Change %
Price: $0.000000
Shares after: 31,930
Date: 08 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 31,930
Exercise price: $65.72
Footnotes: F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 7 footnotes

Footnote F1

Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.

Footnote F2

This is the weighted average sales price representing 2,444 shares sold at prices ranging from $65.85 to $66.21 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Footnote F3

Includes 835 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Footnote F4

Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.

Footnote F5

Each RSU was granted on January 8, 2025 for no consideration.

Footnote F6

This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Footnote F7

These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.